Stay updated on SERENA-1 Clinical Trial Breast Cancer Combination
Sign up to get notified when there's something new on the SERENA-1 Clinical Trial Breast Cancer Combination page.

Latest updates to the SERENA-1 Clinical Trial Breast Cancer Combination page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has been updated to reflect new drug combinations involving AZD9833 for treating ER+ HER2- advanced breast cancer, while significant details about the study's design and inclusion criteria have been removed.SummaryDifference39%
- Check30 days agoChange DetectedThe page has updated its version from v2.14.3 to v2.14.4 and added several new dates for future events, while removing some past dates.SummaryDifference0.7%
- Check37 days agoChange DetectedThe page has been updated to reflect a new version (v2.14.3) and a new last update date of March 25, 2025, replacing the previous estimated update date of December 24, 2024.SummaryDifference0.3%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1.0%
Stay in the know with updates to SERENA-1 Clinical Trial Breast Cancer Combination
Enter your email address, and we'll notify you when there's something new on the SERENA-1 Clinical Trial Breast Cancer Combination page.